06/09/2026
The final day of the 4th Annual Pigmentary Disorders Exchange (PDE) Symposium completely rewrote the playbook.
Day 2 moved us past basic topicals and traditional skin typing, launching straight into next-generation cellular therapies and precision procedural parameters.
If you weren't in the room for the finale, here is a snapshot of the major practice-changing clinical insights now live on the site:
👉 The "Quad Plus" Melasma Evolution: Why standard triple combination creams are making way for advanced compounds featuring topical tranexamic acid (5–7%) and azelaic acid to intercept multiple pathways simultaneously.
👉 Erasing Vitiligo’s "Cellular Memory": A deep dive into the clinical pipeline of IL-15 and CD122 blockade therapies designed to clear resident memory T-cells and freeze site-specific relapses for good.
👉 Ditching Subjective Skin Typing: Why objective pigment meters are becoming non-negotiable in the laser suite to accurately calculate melanin density and prevent iatrogenic darkening.
👉 The Deep Peeling Resurgence: How 88% phenol is emerging as a safer, highly effective alternative to 100% TCA for structural acne scars..
The science of pigmentary disorders is evolving at a breakneck pace. Make sure your clinical protocols are keeping up.
🔗 Read the full Day 2 wrap-up article on Next Steps in Derm! https://ow.ly/4P5B50Z9ywO
